STABILITY OF TACROLIMUS (FK-506) AND CYCLOSPORINE-G IN WHOLE-BLOOD

被引:8
作者
ANNESLEY, TM
HUNTER, BC
FIDLER, DR
GIACHERIO, DA
机构
[1] Department of Pathology, University of Michigan Medical Center, Ann Arbor, MI
关键词
TACROLIMUS; CYCLOSPORINE G; STABILITY; WHOLE BLOOD;
D O I
10.1097/00007691-199508000-00008
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The stability of two new immunosuppressants, tacrolimus and cyclosporin G (CsG), was evaluated in whole blood following incubation of patient specimens at ambient temperature or 4 degrees C for time periods of 2 (48 h) and 7 days (168 h) after collection. No decrease in CsG concentrations was noted over a 7-day period for specimens stored at either ambient temperature or 4 degrees C. For tacrolimus, the concentrations of drug in whole blood stored at ambient temperature for 7 days had a slight downward trend. At 7 days, the ratio of tacrolimus concentrations to day zero concentrations ranged from 0.86 to 1.15, with a mean decrease of 5%. However, these changes are within the published precision characteristics of the tacrolimus immunoassay. Evaluation of a smaller group of whole blood specimens provided evidence of adequate stability of these two drugs over a 13-day period.
引用
收藏
页码:361 / 365
页数:5
相关论文
共 20 条
[1]  
ANNESLEY T, 1987, Journal of Clinical Immunoassay, V10, P226
[2]  
ANNESLEY TM, 1993, CLIN CHEM, V39, P1050
[3]   MULTICENTER COMPARISON OF TACROLIMUS (FK-506) WHOLE-BLOOD CONCENTRATIONS AS MEASURED BY THE ABBOTT IM(X) ANALYZER AND ENZYME-IMMUNOASSAY WITH METHYLENE-CHLORIDE EXTRACTION [J].
DAMBROSIO, R ;
GIRZAITIS, N ;
JUSKO, WJ .
THERAPEUTIC DRUG MONITORING, 1994, 16 (03) :287-292
[4]   VALIDATION AND QUALITY ASSURANCE PROGRAM FOR MONITORING TACROLIMUS (FK-506) CONCENTRATIONS IN PLASMA AND WHOLE-BLOOD [J].
DAMBROSIO, R ;
GIRZAITIS, N ;
JUSKO, WJ .
THERAPEUTIC DRUG MONITORING, 1993, 15 (05) :414-426
[5]   A RANDOMIZED, PROSPECTIVE, DOUBLE-BLINDED TRIAL OF CYCLOSPORINE VS OG37-325 IN CADAVERIC RENAL-TRANSPLANTATION - A PRELIMINARY-REPORT [J].
HENRY, ML ;
TESI, RJ ;
ELKHAMMAS, EA ;
FERGUSON, RM ;
BOLLINGER ;
LEICHTMAN ;
SCHROEDER ;
STARZL .
TRANSPLANTATION, 1993, 55 (04) :748-752
[6]  
KAHAN BD, 1990, CLIN CHEM, V36, P1510
[7]  
KOBAYASHI M, 1991, TRANSPLANT P, V23, P2725
[8]  
LANGMAN LJ, 1994, CLIN CHEM, V40, P613
[9]  
MACHIDA M, 1991, TRANSPLANT P, V23, P2753
[10]  
MCBRIDE JH, 1993, CLIN CHEM, V39, P1415